Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1982 Mar;15(3):456–464. doi: 10.1128/jcm.15.3.456-464.1982

Solid-phase Clq-binding fluorescence immunoassay for detection of circulating immune complexes.

M M Collins, C H Casavant, D P Stites
PMCID: PMC272117  PMID: 6804486

Abstract

A fluorescence immunoassay for detection of immune complexes bound to solid-phase C1q was developed. The method was standardized by using human aggregated immunoglobulin G (IgG) to simulate immune complexes. A linear relationship existed between the concentrations of the aggregated IgG standards and the resulting fluorescent intensity. The method was found to be reproducible and capable of detecting as little as 10 micrograms of aggregated IgG per ml of heat-inactivated human serum. Antigen-antibody complexes prepared in vitro were detectable from equivalence to moderate antigen excess. Endogenous serum C1q inhibited the binding of aggregated IgG to solid-phase C1q. Pretreatment of test sera with EDTA was ineffective in eliminating this competitive effect. Heating the sera at 56 degrees C alleviated, but did not abolish, interference of endogenous C1q. Elevated levels of immune complexes were detectable in sera fro seven of nine patients wit systemic lupus erythematosus, provided the samples were heat inactivated before testing. Heparin and DNA were also found to interfere with the detection of aggregated IgG added to human serum. Assay values were falsely decreased due to competitive inhibition by these anions. Lipopolysaccharides from a variety of bacterial preparations produced no detectable interference. A comparative study was conducted on samples that had previously been tested by fluid-phase C1q-binding radioimmunoassay. The two methods were concordant in assigning normal or elevated levels of immune complexes in 70% of the samples tested. This solid-phase fluorescence immunoassay is proposed as a possible alternative to radioimmunoassay for the detection of circulating immune complexes.

Full text

PDF
456

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abrass C. K., Nies K. M., Louie J. S., Border W. A., Glassock R. J. Correlation and predictive accuracy of circulating immune complexes with disease activity in patients with systemic lupus erythematosus. Arthritis Rheum. 1980 Mar;23(3):273–282. doi: 10.1002/art.1780230302. [DOI] [PubMed] [Google Scholar]
  2. Allan R., Rodrick M., Knobel H. R., Isliker H. Inhibition of the interaction between the complement component Clq and immune complexes. Int Arch Allergy Appl Immunol. 1979;58(2):140–148. doi: 10.1159/000232186. [DOI] [PubMed] [Google Scholar]
  3. Cooper N. R. Activation of the complement system. Contemp Top Mol Immunol. 1973;2:155–183. doi: 10.1007/978-1-4684-7773-3_7. [DOI] [PubMed] [Google Scholar]
  4. Cooper N. R., Morrison D. C. Binding and activation of the first component of human complement by the lipid A region of lipopolysaccharides. J Immunol. 1978 Jun;120(6):1862–1868. [PubMed] [Google Scholar]
  5. Gabriel A., Jr, Agnello V. Detection of immune complexes. The use of radioimmunoassays with Clq and monoclonal rheumatoid factor. J Clin Invest. 1977 May;59(5):990–1001. doi: 10.1172/JCI108722. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Grann V. R., Homewood K., Golden W. Polybrene neutralization as a rapid means of monitoring blood heparin levels. Am J Clin Pathol. 1972 Jul;58(1):26–32. doi: 10.1093/ajcp/58.1.26. [DOI] [PubMed] [Google Scholar]
  7. Griswold W. R., Brams M., McNeal R. The rapidly changing nature of acute immune complex disease. J Lab Clin Med. 1980 Jul;96(1):57–66. [PubMed] [Google Scholar]
  8. Hay F. C., Nineham L. J., Roitt I. M. Routine assay for the detection of immune complexes of known immunoglobulin class using solid phase C1q. Clin Exp Immunol. 1976 Jun;24(3):396–400. [PMC free article] [PubMed] [Google Scholar]
  9. Hughes-Jones N. C., Gardner B. The reaction between the complement subcomponent C1q, IgG complexes and polyionic molecules. Immunology. 1978 Mar;34(3):459–463. [PMC free article] [PubMed] [Google Scholar]
  10. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  11. Nydegger U. E. Biologic properties and detection of immune complexes in animal and human pathology. Rev Physiol Biochem Pharmacol. 1979;85:63–123. doi: 10.1007/BFb0036116. [DOI] [PubMed] [Google Scholar]
  12. Nydegger U. E., Lambert P. H., Gerber H., Miescher P. A. Circulating immune complexes in the serum in systemic lupus erythematosus and in carriers of hepatitis B antigen. Quantitation by binding to radiolabeled C1q. J Clin Invest. 1974 Aug;54(2):297–309. doi: 10.1172/JCI107765. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Robinson M. F., Roberts J. L., Jones J. V., Lewis E. J. Circulating immune complex assays in patients with lupus and membranous glomerulonephritis. Clin Immunol Immunopathol. 1979 Nov;14(3):348–360. doi: 10.1016/0090-1229(79)90160-0. [DOI] [PubMed] [Google Scholar]
  14. Rossen R. D., Zubler R. H., Day N. K., Reisberg M. A., Morgan A. C., Gutterman J. U., Hersh E. M. Detection of immune complex-like materials in cancer patients' sera: a comparative study of results obtained with the C1q deviation and C1q binding tests. J Lab Clin Med. 1978 Feb;91(2):191–204. [PubMed] [Google Scholar]
  15. Soini E., Hemmilä I. Fluoroimmunoassay: present status and key problems. Clin Chem. 1979 Mar;25(3):353–361. [PubMed] [Google Scholar]
  16. Soltis R. D., Morris M. J., Hasz D. E., Wilson I. D. The influence of endogenous serum C1q on the 125I-C1q binding test. J Lab Clin Med. 1979 Feb;93(2):238–245. [PubMed] [Google Scholar]
  17. Svehag S. E. A solid-phase radioimmunoassay for C1q-binding immune complexes. I. Delta IgG as indicator molecule. Scand J Immunol. 1975;4(7):687–697. doi: 10.1111/j.1365-3083.1975.tb02677.x. [DOI] [PubMed] [Google Scholar]
  18. Teien A. N., Lie M. Heparin assay in plasma: a comparison of five clotting methods. Thromb Res. 1975 Nov;7(5):777–788. doi: 10.1016/0049-3848(75)90202-9. [DOI] [PubMed] [Google Scholar]
  19. Teppo A. M., Wager O. Heating at 56 degrees C does not eliminate immune complex-bound Clq. Scand J Immunol. 1979;10(5):431–435. doi: 10.1111/j.1365-3083.1979.tb01372.x. [DOI] [PubMed] [Google Scholar]
  20. Theofilopoulos A. N., Dixon F. J. The biology and detection of immune complexes. Adv Immunol. 1979;28:89–220. doi: 10.1016/s0065-2776(08)60800-7. [DOI] [PubMed] [Google Scholar]
  21. Zubler R. H., Lange G., Lambert P. H., Miescher P. A. Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus. J Immunol. 1976 Jan;116(1):232–235. [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES